The Essilor International SA (ESLOY) Upgraded by Zacks Investment Research to Hold

The Essilor International SA (ESLOY) Upgraded by Zacks Investment Research to Hold

Essilor International SA (NASDAQ:ESLOY) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a report released on Thursday.

According to Zacks, “Essilor International researches, develops, manufactures and markets around the world a wide range of lenses to improve and protect eyesight. It creates lenses for various types of visual disorders such as myopia, hypermetropia, presbyopia and stigmatism. The group’s know-how also covers the manufacture and sale of optical instruments mainly machines used to edge finished lenses and diagnose visual disorders. The Company sells its products through various flagship brands such as Varilux, Crizal, Essilor, Definity and Xperio. Essilor International is headquartered in Charenton-le-Pont, France. “

Shares of Essilor International SA (NASDAQ:ESLOY) traded down 3.46% on Thursday, reaching $58.62. The company had a trading volume of 42,077 shares. The company has a 50-day moving average price of $0.00 and a 200-day moving average price of $0.00. Essilor International SA has a one year low of $50.35 and a one year high of $67.99.

About Essilor International SA

Essilor International SA, formerly Essilor International Compagnie Generale D’Optique SA, is an ophthalmic optics company. The Company designs, manufactures and markets a range of lenses to improve and protect eyesight. It also develops and markets equipment for prescription laboratories, and instruments and services for eye care professionals.

Get a free copy of the Zacks research report on Essilor International SA (ESLOY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Related posts

Leave a Comment